Shaohua Gou

697 total citations
26 papers, 588 citations indexed

About

Shaohua Gou is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Shaohua Gou has authored 26 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 15 papers in Organic Chemistry and 10 papers in Molecular Biology. Recurrent topics in Shaohua Gou's work include Metal complexes synthesis and properties (18 papers), Ferrocene Chemistry and Applications (7 papers) and Synthesis and biological activity (6 papers). Shaohua Gou is often cited by papers focused on Metal complexes synthesis and properties (18 papers), Ferrocene Chemistry and Applications (7 papers) and Synthesis and biological activity (6 papers). Shaohua Gou collaborates with scholars based in China and Bangladesh. Shaohua Gou's co-authors include Feihong Chen, Xiaochao Huang, Zhimei Wang, Heng‐Shan Wang, Ri-Zhen Huang, Zhi‐Xin Liao, Lei Fang, Weiwei Hu, Xiaodong Qin and Jianglin Fang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Biochemical Pharmacology and Cancer Letters.

In The Last Decade

Shaohua Gou

26 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaohua Gou China 16 343 334 189 67 65 26 588
Emanuele Petruzzella United States 11 439 1.3× 331 1.0× 153 0.8× 45 0.7× 100 1.5× 17 575
Simone Göschl Austria 13 418 1.2× 357 1.1× 172 0.9× 67 1.0× 91 1.4× 13 580
Bing Tang China 17 454 1.3× 389 1.2× 237 1.3× 61 0.9× 105 1.6× 32 727
Miao He China 16 386 1.1× 291 0.9× 245 1.3× 31 0.5× 85 1.3× 24 622
Michele De Franco Italy 15 202 0.6× 269 0.8× 151 0.8× 77 1.1× 33 0.5× 32 532
Juraj Zajac Czechia 11 314 0.9× 242 0.7× 137 0.7× 38 0.6× 86 1.3× 13 457
Ilaria Zanellato Italy 19 528 1.5× 365 1.1× 308 1.6× 28 0.4× 115 1.8× 30 787
Arvin Eskandari United Kingdom 15 454 1.3× 272 0.8× 249 1.3× 98 1.5× 138 2.1× 23 741
Sonja Hager Austria 14 271 0.8× 168 0.5× 202 1.1× 63 0.9× 67 1.0× 21 530
M. Pongratz Austria 7 515 1.5× 374 1.1× 181 1.0× 71 1.1× 115 1.8× 8 676

Countries citing papers authored by Shaohua Gou

Since Specialization
Citations

This map shows the geographic impact of Shaohua Gou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaohua Gou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaohua Gou more than expected).

Fields of papers citing papers by Shaohua Gou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaohua Gou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaohua Gou. The network helps show where Shaohua Gou may publish in the future.

Co-authorship network of co-authors of Shaohua Gou

This figure shows the co-authorship network connecting the top 25 collaborators of Shaohua Gou. A scholar is included among the top collaborators of Shaohua Gou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaohua Gou. Shaohua Gou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Feihong, et al.. (2020). Dual-functional conjugates improving cancer immunochemotherapy by inhibiting tubulin polymerization and indoleamine-2,3-dioxygenase. European Journal of Medicinal Chemistry. 189. 112041–112041. 15 indexed citations
3.
Chen, Feihong, et al.. (2019). Emerging JWA-targeted Pt(IV) prodrugs conjugated with CX-4945 to overcome chemo-immune-resistance. Biochemical and Biophysical Research Communications. 521(3). 753–761. 10 indexed citations
4.
Chen, Feihong, et al.. (2019). Multifunctional platinum(IV) complexes as immunostimulatory agents to promote cancer immunochemotherapy by inhibiting tryptophan-2,3-dioxygenase. European Journal of Medicinal Chemistry. 169. 29–41. 25 indexed citations
5.
Chen, Feihong, et al.. (2019). Pt(IV) hybrids containing a TDO inhibitor serve as potential anticancer immunomodulators. Journal of Inorganic Biochemistry. 195. 130–140. 17 indexed citations
7.
Chen, Feihong, et al.. (2019). Microtubule inhibitors containing immunostimulatory agents promote cancer immunochemotherapy by inhibiting tubulin polymerization and tryptophan-2,3-dioxygenase. European Journal of Medicinal Chemistry. 187. 111949–111949. 12 indexed citations
8.
Huang, Xiaochao, Ri-Zhen Huang, Zhikun Liu, et al.. (2018). Dual-targeting antitumor hybrids derived from Pt(IV) species and millepachine analogues. European Journal of Medicinal Chemistry. 148. 1–25. 29 indexed citations
9.
Huang, Xiaochao, Ri-Zhen Huang, Zhimei Wang, et al.. (2018). Pt(IV) complexes conjugating with chalcone analogue as inhibitors of microtubule polymerization exhibited selective inhibition in human cancer cells. European Journal of Medicinal Chemistry. 146. 435–450. 29 indexed citations
10.
Huang, Xiaochao, et al.. (2017). Synthesis and biological evaluation of novel chalcone derivatives as a new class of microtubule destabilizing agents. European Journal of Medicinal Chemistry. 132. 11–25. 33 indexed citations
11.
Huang, Xiaochao, Ri-Zhen Huang, Shaohua Gou, et al.. (2017). Platinum(IV) complexes conjugated with phenstatin analogue as inhibitors of microtubule polymerization and reverser of multidrug resistance. Bioorganic & Medicinal Chemistry. 25(17). 4686–4700. 23 indexed citations
12.
Hu, Weiwei, et al.. (2017). Platinum(IV) prodrugs multiply targeting genomic DNA, histone deacetylases and PARP-1. European Journal of Medicinal Chemistry. 141. 211–220. 29 indexed citations
13.
Qin, Xiaodong, Lei Fang, Feihong Chen, & Shaohua Gou. (2017). Conjugation of platinum(IV) complexes with chlorambucil to overcome cisplatin resistance via a “joint action” mode toward DNA. European Journal of Medicinal Chemistry. 137. 167–175. 48 indexed citations
14.
Chen, Feihong, Xiaochao Huang, Mian Wu, Shaohua Gou, & Weiwei Hu. (2016). A CK2-targeted Pt(IV) prodrug to disrupt DNA damage response. Cancer Letters. 385. 168–178. 42 indexed citations
15.
Zhao, Junjun, et al.. (2016). Synthesis and biological evaluation of new [1,2,4]triazolo[4,3-a]pyridine derivatives as potential c-Met inhibitors. Bioorganic & Medicinal Chemistry. 24(16). 3483–3493. 11 indexed citations
16.
Qin, Xiaodong, et al.. (2016). Synthesis, cytotoxicity, and interaction with DNA of platinum(II) complexes of (1R,2R)-N1-2-amyl-1,2-diaminocyclohexane. Journal of Coordination Chemistry. 69(10). 1653–1662. 8 indexed citations
17.
Yu, Haiyan, Shaohua Gou, Zhimei Wang, Feihong Chen, & Lei Fang. (2016). Toward overcoming cisplatin resistance via sterically hindered platinum(II) complexes. European Journal of Medicinal Chemistry. 114. 141–152. 17 indexed citations
18.
Yin, Runting, Shaohua Gou, Yanyan Sun, & Xia Liu. (2012). In vitro biological evaluation of platinum(II) complexes with 1-(methoxy substituted benzyl) azetidine-3,3-dicarboxylato ligands. Bioorganic & Medicinal Chemistry. 20(4). 1461–1467. 5 indexed citations
19.
Huang, Wei, et al.. (2004). A novel tetranuclear copper(II) complex with 3,5-pyridinedicarboxylate bridges. Polyhedron. 23(7). 1169–1173. 20 indexed citations
20.
Zeng, Qingdao, et al.. (1998). Synthesis and spectroscopic studies of dinuclear copper(II) complexes with new pendant-armed macrocyclic ligands. Transition Metal Chemistry. 23(4). 371–373. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026